Falciparum Malaria Clinical Trial
Official title:
Azithromycin Combination Therapy for the Treatment of Severe Malaria - A Pilot Safety and Efficacy Study in Uncomplicated Falciparum Malaria in Bangladesh
A randomized controlled trial to assess the safety and efficacy of azithromycin combination therapy for use in severe malaria. This pilot trial will be conducted in uncomplicated malaria patients in southeastern Bangladesh.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00440752 -
The Impact of Artemether-Lumefantrine on Genes Associated With Antimalarial Resistance
|
N/A | |
| Completed |
NCT01144702 -
Effectiveness of the Association Artesunate and Mefloquine in the Treatment of Malaria by Plasmodium Falciparum
|
Phase 2/Phase 3 | |
| Terminated |
NCT00400101 -
Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Peptides
|
Phase 1 | |
| Completed |
NCT01350856 -
Tracking Resistance to Artemisinin (TRAC)
|
Phase 4 | |
| Completed |
NCT00859807 -
A Bioequivalence Study Comparing Camoquin® Suspension (Pfizer) To Flavoquine® Tablets (Sanofi Aventis) In Healthy Subjects
|
Phase 4 | |
| Completed |
NCT04222088 -
TES of Artemether-lumefantrine for Pf and Chloroquine for Pv in the Philippines From 2013-2014
|
||
| Completed |
NCT01115439 -
Artesunate+Sulfadoxine-Pyrimethamine for the Treatment of Uncomplicated Falciparum Malaria
|
N/A | |
| Completed |
NCT00282919 -
A Three Day Trial of Azithromycin Plus Chloroquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria
|
Phase 2 | |
| Completed |
NCT04422015 -
Biological Mechanisms in Afebrile P. Falciparum Malaria
|
||
| Completed |
NCT00894660 -
A Bioequivalence Study Comparing Amodiaquine Tablet (Pfizer) To Amodiaquine Tablets (Arsuamoon-Guilin China) In Healthy Subjects
|
Phase 1 | |
| Completed |
NCT00894374 -
Bioequivalence Study Comparing Artesunate Tablet To Arsuamoon® Tablets (Guilin-China) In Healthy Subjects
|
Phase 1 | |
| Completed |
NCT00493363 -
Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western Cambodia
|
N/A | |
| Completed |
NCT00158548 -
ACT With Chloroquine, Amodiaquine & Sulphadoxine-pyrimethamine in Pakistan
|
Phase 3 | |
| Withdrawn |
NCT04289558 -
Nitrite Infusion in Children With Malaria
|
Phase 1 | |
| Completed |
NCT00722150 -
Artemisinin Resistance in Cambodia II
|
N/A | |
| Completed |
NCT00157833 -
A Randomized Trial of Coartemether and Artekin for the Treatment of Uncomplicated Malaria in Papua, Indonesia.
|
N/A | |
| Completed |
NCT00513669 -
Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania
|
Phase 1 | |
| Completed |
NCT00403260 -
Pyronaridine - Artesunate (3:1) Versus Mefloquine Plus Artesunate in Plasmodium Falciparum Malaria Patients
|
Phase 3 | |
| Completed |
NCT00442377 -
Study to Investigate the Induction of an Protective Immune Response to Malaria
|
N/A | |
| Completed |
NCT01365598 -
Evaluation of the Gametocytocidal Efficacy and Safety of Primaquine in Uncomplicated Falciparum Malaria in Uganda
|
Phase 3 |